Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT00033137
What this trial is testing

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Who this might be right for
Kidney NeoplasmsKidney CancerPneumothorax+1 more
National Cancer Institute (NCI) 950
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07689240
What this trial is testing

Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8
National Cancer Institute (NCI) 400
Not applicableStudy completedNCT06775574
What this trial is testing

Prognostic Significance of the Lung Immune Prognostic Index (LIPI) in Postoperative Clear Cell Renal Cell Carcinoma: a Multicenter Retrospective Cohort Study

Who this might be right for
ccRCC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 704
Testing effectiveness (Phase 2)Looking for participantsNCT07049926
What this trial is testing

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 140
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Not applicableStudy completedNCT04957160
What this trial is testing

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Ipsen 281
Not applicableActive Not RecruitingNCT06453642
What this trial is testing

Evaluation of a Simple-Prep Controlled Embolic

Who this might be right for
EmbolizationVascular TumorRenal Angiomyolipoma+3 more
Fluidx Medical Technology, Inc. 114
Not applicableStudy completedNCT03519542
What this trial is testing

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 62
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Post-approval studies (Phase 4)Study completedNCT00172003
What this trial is testing

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Who this might be right for
Renal Cell CancerNeoplasm Metastasis
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT05877820
What this trial is testing

Evaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCC

Who this might be right for
Fumarate Hydratase Deficient Renal Cell Carcinoma
RenJi Hospital 20
Not applicableWithdrawnNCT00908739
What this trial is testing

Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Post-approval studies (Phase 4)Study completedNCT00706706
What this trial is testing

Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer 105
Testing effectiveness (Phase 2)Study completedNCT02843607
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

Who this might be right for
Metastatic Renal Cell Cancer
Fuda Cancer Hospital, Guangzhou 30
Early research (Phase 1)Study completedNCT00005816
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Duke University 15
Not applicableStudy completedNCT05735977
What this trial is testing

Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared

Who this might be right for
Wilms TumorRenal Cancer
Birmingham Women's and Children's NHS Foundation Trust 12
Next Page